Investment Summary |
|
---|---|
Date | 2018-02-15 |
Target | Smart Medical Systems |
Sector | Medical Products |
Investor(s) | Signet Healthcare Partners |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1998 |
PE ASSETS | 600M USD |
Size | Middle-Market |
Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
DEAL STATS | # |
---|---|
Overall | 7 of 15 |
Sector (Medical Products) | 2 of 3 |
Type (Venture) | 4 of 4 |
Country (Israel) | 1 of 1 |
Year (2018) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-12-28 |
Leading Pharma
Fairfield, New Jersey, United States Leading Pharma is a privately-owned generic pharmaceutical company that purchases, licenses, develops, manufactures, and distributes high-quality, safe and effective products to drugstore chains, distributors, wholesalers, mass merchandisers, government agencies and managed care accounts in the U.S. Leading Pharma's products are available in various dosage forms across many therapeutic areas under the Leading Pharma label. Leading Pharma was founded in 2014 and is based in Fairfield, New Jersey. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-04-22 |
Goodwin Biotechnology
Plantation, Florida, United States Goodwin Biotechnology is a uniquely qualified and flexible, US-based CDMO that offers a Single Source Solution™ for their clients from cell line development, exploratory proof-of-concept projects through process development and cGMP contract manufacturing of monoclonal antibodies, recombinant proteins, vaccines, and Biologic Drug Conjugates including Antibody Drug Conjugates (ADCs) for early- and late-stage clinical trials. Goodwin Biotechnology is based in Plantation, Florida. |
Buy | - |